The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes

Background Clonal hematopoiesis of indeterminate potential (CHIP) has been reported to be associated with increased cardiovascular disease, aging and insulin resistance. Despite the debate of causal contribution of CHIP on metabolic diseases, we want to explore whether CHIP is related to diabetic pe...

Full description

Bibliographic Details
Main Authors: Tae Jung Oh, Han Song, Youngil Koh, Sung Hee Choi
Format: Article
Language:English
Published: Korean Endocrine Society 2022-04-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2021-1337.pdf
_version_ 1811302857741172736
author Tae Jung Oh
Han Song
Youngil Koh
Sung Hee Choi
author_facet Tae Jung Oh
Han Song
Youngil Koh
Sung Hee Choi
author_sort Tae Jung Oh
collection DOAJ
description Background Clonal hematopoiesis of indeterminate potential (CHIP) has been reported to be associated with increased cardiovascular disease, aging and insulin resistance. Despite the debate of causal contribution of CHIP on metabolic diseases, we want to explore whether CHIP is related to diabetic peripheral neuropathy (DPN). Methods This study analyzed the prevalence of CHIP in patients with type 2 diabetes classified according to DPN status. Logistic regression analysis was used to evaluate the association between CHIP and DPN. Results CHIP was more prevalent in subjects without DPN than those with DPN (19.9% vs. 8.8%, respectively; P=0.013). Individuals having any CHIP, or DNA methyltransferase 3A (DNMT3A) CHIP were less likely to have any abnormality shown in DPN test; the adjusted odds ratio were 0.85 (95% confidence interval [CI], 0.73 to 1.00) and 0.70 (95% CI, 0.56 to 0.89), respectively. Interestingly, DNMT3A CHIP showed the negative association, but Tet methylcytosine dioxygenase 2 (TET2) CHIP showed the positive association with abnormal feet electrochemical skin conductance level. Conclusion On the contrary to expectations, CHIP was negatively associated with DPN. Functional linking between the mutation in hematopoietic cells and DPN, and the opposite role of DNMT3A and TET2 should be investigated.
first_indexed 2024-04-13T07:36:52Z
format Article
id doaj.art-5a1125ad88f24276995bb94c5a6b2973
institution Directory Open Access Journal
issn 2093-596X
2093-5978
language English
last_indexed 2024-04-13T07:36:52Z
publishDate 2022-04-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj.art-5a1125ad88f24276995bb94c5a6b29732022-12-22T02:56:07ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782022-04-0137224324810.3803/EnM.2021.13372291The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 DiabetesTae Jung Oh0Han Song1Youngil Koh2Sung Hee Choi3 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Genome Opinion Incorporation, Seoul, Korea Genome Opinion Incorporation, Seoul, Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, KoreaBackground Clonal hematopoiesis of indeterminate potential (CHIP) has been reported to be associated with increased cardiovascular disease, aging and insulin resistance. Despite the debate of causal contribution of CHIP on metabolic diseases, we want to explore whether CHIP is related to diabetic peripheral neuropathy (DPN). Methods This study analyzed the prevalence of CHIP in patients with type 2 diabetes classified according to DPN status. Logistic regression analysis was used to evaluate the association between CHIP and DPN. Results CHIP was more prevalent in subjects without DPN than those with DPN (19.9% vs. 8.8%, respectively; P=0.013). Individuals having any CHIP, or DNA methyltransferase 3A (DNMT3A) CHIP were less likely to have any abnormality shown in DPN test; the adjusted odds ratio were 0.85 (95% confidence interval [CI], 0.73 to 1.00) and 0.70 (95% CI, 0.56 to 0.89), respectively. Interestingly, DNMT3A CHIP showed the negative association, but Tet methylcytosine dioxygenase 2 (TET2) CHIP showed the positive association with abnormal feet electrochemical skin conductance level. Conclusion On the contrary to expectations, CHIP was negatively associated with DPN. Functional linking between the mutation in hematopoietic cells and DPN, and the opposite role of DNMT3A and TET2 should be investigated.http://www.e-enm.org/upload/pdf/enm-2021-1337.pdfdiabetic neuropathiesclonal hematopoiesisrisk factors
spellingShingle Tae Jung Oh
Han Song
Youngil Koh
Sung Hee Choi
The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
Endocrinology and Metabolism
diabetic neuropathies
clonal hematopoiesis
risk factors
title The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
title_full The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
title_fullStr The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
title_full_unstemmed The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
title_short The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
title_sort presence of clonal hematopoiesis is negatively associated with diabetic peripheral neuropathy in type 2 diabetes
topic diabetic neuropathies
clonal hematopoiesis
risk factors
url http://www.e-enm.org/upload/pdf/enm-2021-1337.pdf
work_keys_str_mv AT taejungoh thepresenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT hansong thepresenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT youngilkoh thepresenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT sungheechoi thepresenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT taejungoh presenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT hansong presenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT youngilkoh presenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes
AT sungheechoi presenceofclonalhematopoiesisisnegativelyassociatedwithdiabeticperipheralneuropathyintype2diabetes